Roopa Industries Ltd.

BSE: ROOPAIND · Pharmaceuticals · sector

₹41.63BSE close 2026-10-26

Key numbers

Market cap₹33 cr

Price₹41.63

52w high / low₹63 / ₹38

P/E10.9xSector median 27.9x

P/B1.9xSector median 2.9x

Book value₹22.4

Dividend yield–Sector median 0.48%

ROE0.7%Sector median 11.7%

ROCE7.3%Sector median 12.3%

OPM3.3%Sector median 14.0%

Debt / equity1.76xSector median 0.16x

EV/EBITDA14.9xSector median 18.6x

Interest cover1.1x

Current ratio1.25x

Sales growth 3y+18.7%Sector median +9.6%

Profit growth 3y-60.5%Sector median +13.3%

PEG0.55x

Last 12 months to Jun 2026, Standalone. "Sector median" = middle value of 185 companies in Pharmaceuticals (P/E median leaves out loss-making companies). Tap ? for what a number means.

Things to know

Cash ₹2 cr vs borrowings ₹31 cr (FY26): borrowings are higher by ₹29 cr.
Operating profit covered interest 1.1x in the last 12 months.
Net loss in 1 of the last 6 quarters.
Other income was 108% of net profit in the last 12 months.
No dividend in the last 5 financial years.
Price ₹41.63 on 2026-10-26: -34.3% from the 52-week high, +9.3% from the 52-week low.

Plain facts from the filings, built by the same fixed rules for every company. A line appears only when the data for it is available. Not a view on the stock.

Charts

Weekly close · high ₹104.63 · low ₹41.63

Quarterly results

₹ cr	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	30	35	29	34	30	33
EBITDA	0	1	2	2	-1	2
OPM %	1.5%	4.0%	5.7%	6.1%	-3.4%	4.6%
Other income	1	0	0	0	0	0
Net profit	0	0	0	1	-1	0
EPS (₹)	0.51	0.36	0.59	0.98	1.80	0.43
Revenue YoY					+1.0%	-5.0%
Profit YoY					-440.5%	+17.9%

Standalone figures where filed. Latest quarter Jun 2026.

Profit & loss (yearly)

₹ cr	FY22	FY23	FY24	FY25	FY26	TTM
Revenue	47	76	70	121	128	126
EBITDA	-1	4	5	4	4	4
Net profit	1	1	2	2	0	0
EPS (₹)	1.30	1.73	1.95	2.57	2.97	3.80
Revenue growth		+63.0%	-7.5%	+71.4%	+5.6%	–
Profit growth		+32.4%	+12.6%	+34.2%	-96.1%	–
Dividend / share (₹)	–	–	–	–	–

Compounded growth	3 years	5 years	Last 12 months
Sales	+18.7%	–	–
Net profit	-60.5%	–	–
EPS	+19.7%	–	–
Share price	–	-34.7% (2y)	-18.8%

Balance sheet

₹ cr	FY25	FY26
Shareholders' equity	17	18
Borrowings	33	31
Cash & equivalents	5	2
Total assets	76	72
Fixed assets	8	8
Capital work in progress	1	0
Investments	0	0
Receivables	13	22
Inventory	36	31
Payables	17	13

Year-end figures from the March annual filing.

Cash flow

₹ cr	FY25	FY26
Cash from operations	-7	5
Cash from investing	2	-0
Cash from financing	5	-8
Capex	1	1
Free cash flow	-7	4

Free cash flow = cash from operations − capex.

Ratios by year

₹ cr	FY25	FY26
ROE %	11.6%	0.5%
ROCE %	10.9%	7.0%
Debtor days	39	63
Inventory days	121	102
Payable days	56	41
Cash conversion cycle (days)	104	124
Working capital days	50	37

Peers in Pharmaceuticals

Company	Market cap	P/E	P/B	ROE	ROCE	OPM	Sales 3y	Div yield
SUNPHARMA	₹4,17,478 cr	34.5x	5.0x	15.5%	18.7%	28.6%	+10.0%	0.94%
DIVISLAB	₹2,39,825 cr	82.1x	14.3x	18.4%	23.0%	34.7%	+10.8%	0.34%
TORNTPHARM	₹1,53,999 cr	72.7x	18.4x	27.3%	15.1%	32.3%	+13.3%	0.84%
ZYDUSLIFE	₹1,15,808 cr	25.9x	4.3x	17.7%	16.8%	27.2%	+16.4%	0.95%
LAURUSLABS	₹1,11,232 cr	101.6x	21.0x	22.4%	20.8%	28.0%	+4.1%	0.08%
CIPLA	₹1,09,464 cr	32.5x	3.2x	10.3%	13.2%	17.7%	+7.4%	1.18%
DRREDDY	₹1,09,460 cr	33.9x	2.9x	9.0%	10.1%	15.5%	+11.0%	0.61%
MANKIND	₹95,486 cr	46.7x	5.9x	13.4%	13.8%	25.1%	+17.7%	0.04%
AUROPHARMA	₹91,489 cr	24.9x	2.4x	10.5%	12.8%	20.0%	+10.6%	0.26%
ROOPAIND	₹33 cr	10.9x	1.9x	0.7%	7.3%	3.3%	+18.7%	–

All 185 companies in Pharmaceuticals →

Documents

Links go to the original files on the exchange website.

About the company


Sector	Healthcare
Industry	Pharmaceuticals
Sub-industry	Pharmaceuticals
Symbol	ROOPAIND
BSE code	530991
ISIN	INE443C01010
Face value	₹10.0
Incorporated	–
Website	–
Plants (India / abroad)	–

Data built 2026-10-24 from BSE company filings (inline XBRL: Integrated Filing - Finance) + BSE results summary for earlier years; price = BSE close 2026-10-26.